探索用于多目标免疫调节疗法的甲基酸基架
Raquel Gil-Edo1, German Hernández-Ribelles2, Santiago Royo3
1Inorganic and Organic Chemistry Department, University Jaume I, 12071 Castellón, Spain.
International journal of molecular sciences
|May 27, 2023
概括
新的甲基基尿酸通过抑制关键蛋白质和增强免疫反应,显示出作为癌症治疗的前景. 这些多目标抑制剂为克服癌症抵抗力和开发新型免疫增强剂提供了潜力.
科学领域:
- 药用化学 医学化学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 癌症对疗法的耐药性是一个重大挑战.
- 针对多种途径,包括血管新生和免疫检查点,对于有效的癌症治疗至关重要.
- 开发新的小分子免疫强化剂 (SMIP) 可以增强抗瘤免疫力.
研究的目的:
- 合成和评估甲基氨酸作为VEGFR-2和PD-L1.1的多目标抑制剂.
- 评估这些化合物的抗增殖活性和选择性指数与各种细胞系相比.
- 研究这些化合物作为抗癌剂和免疫增强剂的潜力.
主要方法:
- 合成十三种基基尿酸.
- 生物评估包括对瘤,内皮细胞,免疫细胞和非瘤细胞系的抗增殖试验.
- 选择性指数 (SI) 的确定和CD11b表达和T细胞活动的评估.
主要成果:
- 含有p替代的氨酸和氨酸化合物的选择性指数很高.
- 设计的尿素显示出良好的瘤抗血管性质.
- 观察到抑制CD11b表达和调节CD8T细胞活动通路.
结论:
- 甲基氨酸是VEGFR-2和PD-L1.1的有效多目标抑制剂.
- 选择的化合物表现出有利的抗癌和免疫强化特性.
- 这些尿素有潜力开发新的癌症免疫治疗方法.
关键词:
在 CD11b 中,CD11b 是 CD11b 的第一个单元.CD69 CD69 是一个在 CD8+ T 细胞中.菲恩 (Fyn Fyn) 是一个很好的地方.现场行动组-3拉丁美洲 拉丁美洲 拉丁美洲在 LCKCK LCK 中.在OX-40中使用OX-40.在PD-1中使用PD-1.在PD-L1中.在TIM-3中,TIM-3是TIM-3.这就是TLCRs.在VEGFR-2的基础上,在ZAP7070中使用.血管新生的产生.亚利尿素 (aryl urea) 是一种氨基酸.甲基基氨酸 (benzylethoxyaryl urea) 是一种甲基氨酸.免疫检查点的检查点.更多相关视频
08:47Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
9.5K
09:17Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
365
相关概念视频
Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
